Global Life Sciences BPO Market, By Service Type (Medical Device Outsourcing and Pharmaceutical Outsourcing), End User (Healthcare Providers and Healthcare Payers) and by Geography - Trends and Forecast to 2024

Life Sciences BPO Services – Helping healthcare companies improve ROI and upscale their business

The healthcare industry is characterized by high competition, increased cost pressure, and decreasing research and development (R&D) productivity, which is compelling pharmaceutical and biotech companies to make strategic collaborations and outsource their non-core activities. Pharmaceutical, biotech, and medical device players alike are outsourcing processes related to manufacturing, product research, and regulatory process services, among others to contract manufacturing and contract research organizations. This helps them to focus on their core strengths and in turn improve productivity. The global life sciences BPO market is analyzed for various service types such as medical device outsourcing, pharmaceutical outsourcing, and regulatory information. The global life sciences BPO market was valued at US$ 180.4 billion in 2015 and is expected to expand at a CAGR of 12.2% during the forecast period considered (2016 – 2024).

Figure 1. Global Life Sciences BPO Market Size and Forecast, US$ Billion and Y-o-Y Growth (%), 2014-2024

Life Science BPO Market 

Source: Coherent Market Insights Analysis (2017)

To have a snippet of the report, request Report Sample

Patent expirations to boost the prospects for life sciences BPO market

According to UBM India Pharma Publication, over US$ 40 billion worth of drug are expected to be off-patent in the U.S. by 2017. Also, in 2014, utilization of generic drugs resulted in savings of around US$ 254 billion in the U.S. This trend is anticipated to increase further with more patent expirations in the near future. This factor coupled with the advent of biosimilars is projected to favor the growth of life sciences BPO market over the forecast period.

India home to second-highest number of U.S. FDA approved manufacturing facilities, an attractive proposition for India’s life sciences BPO market

Demand for contract manufacturing and contract research services in Asia is high, mainly due to large number of FDA approved drug manufacturing plants in this region. According to the UBM India Pharma Publication report of 2015, Indian accounts for 22% of the overall U.S. FDA approved drug manufacturing facilities globally.  Moreover, dynamics such as wide availability of highly trained professionals, cheap labor, large patient pool, and easy availability of subjects for clinical trials are positioning Asia Pacific as a major life sciences BPO market.  The life sciences BPO market in this region is expected to expand at a CAGR of 16.6% during the forecast period.

Uncertainty and differences in government regulations to increase demand for regulatory outsourcing services

Healthcare companies are subject to highly uncertain regulations that change according to country and changing government priorities. For instance, Section 3d of the Indian Pharma Act does not approve any new drug that is an altered form of a known molecule and not representing an improved efficacy over the existing molecule. While this drug is approved in the U.S., U.K, Australia and other countries. Dismissal of such patent applications discourages investment in countries with high growth potential. Also, mandatory licensing and patent ever-greening strategies further makes regulatory filing in a country more complex. Hence, healthcare companies hire regulatory experts of the respective countries to execute the regulatory process smoothly in that particular country.

Import and distribution of drug or medical devices in several countries require regulatory clearance that is efficiently managed by life science BPO companies. This enables pharmaceutical, biotech and medical device companies to focus on their core activities such as research, marketing, distribution agreements, and increasing product availability. The regulatory information segment is expected to grow swiftly to reach US$ 35 billion by 2024, on account of increasing abbreviated new drug application (ANDA) filings and growing interest in biosimilars.

Life science business process outsourcing (BPO) is one of the most lucrative industries in the healthcare sector. Constantly rising pricing pressure and increasing competition is compelling pharmaceutical and medical device companies to strategically reduce their operational costs and in turn benefit from higher profits. This has led to an increasing demand for contract manufacturing outsourcing (CMO) and contract research outsourcing (CRO) services. Asia and Latin America are the most attractive markets for CMO and CRO, owing to low costs of production and research activities performed here.

Market Dynamics

The global life sciences BPO market is driven by factors such as increasing cost of research and development (R&D), growing price pressures, and increase in investments by pharmaceutical and medical devices companies in emerging economies such as India, China, Brazil, and South Africa. Pharmaceutical and medical device companies are adopting inorganic growth strategies to expand their business and reduce their Capital Expenditure (CAPEX) and Operation Costs (OPEX). However, outsourcing certain services to different CMO and CRO companies located in other countries is a challenge for the outsourcing company to monitor and follow a particular set of guideline for product approval pertaining to regulatory filings, clinical trials and medical writing. Collaborative efforts among various stakeholders of the ecosystem is analyzed to benefit the life science BPO industry in the long run.

Market Taxonomy

This report segments the life sciences BPO market on the basis of service type and end user. On the basis of service type, the global life sciences BPO market is analyzed for medical device outsourcing, pharmaceuticals outsourcing and regulatory information. The end users covered in the report are healthcare providers and healthcare payers.

Key features of the study:

  • This report provides in-depth analysis of the life sciences BPO industry and provides market size (US$ Billion) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2016 – 2024), considering 2015 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides vital insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global life sciences BPO market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
  • Key companies covered as a part of this study include Anthelio Healthcare Solutions, Accenture plc, Cognizant Technology Solutions, Catalent, Inc., Covance, Inc., Boehringer Ingelheim GmbH, Genpact Limited, Lonza Group, PAREXEL International Corporation and Quintiles Transnational Corporation.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision with respect to manufacturing or research outsourcing, cost reduction opportunities, and operational strategies
  • The global life sciences BPO market report caters to various stakeholders in this industry including investors, pharmaceutical and medical device companies, contract manufacturers, contract research organizations, medical writing companies, pharmacovigilance companies, new entrants, and financial analysts
  • Stakeholders would greatly benefit from various strategy matrices used in analyzing the life sciences BPO market, which would aid in effective decision making

 

Detailed Segmentation:

  • Global Life Sciences BPO Market, By Service Type:
    • Medical Device Outsourcing
    • Pharmaceutical Outsourcing
      • CMO
        • API Manufacturing
        • Final dosage form manufacturing
        • Packaging
      • CRO
        • Drug Discovery
        • Preclinical studies
        • Early Phase I - IIa
        • Phase IIa - III
        • Phase IIIb - IV
        • Medical coding and writing
        • Monitoring
        • Clinical Data Management
        • Bio-statistics
        • Site management
        • Protocol development
    • Regulatory Information
  • Global Life Sciences BPO Market, By End User:
    • Healthcare Providers
    • Healthcare Payers
  • Global Life Sciences BPO Market, By Geography:
    • North America
      • U.S.
        • By Service Type:
          • Medical Device Outsourcing
          • Pharmaceutical Outsourcing
            • CMO
              • API Manufacturing
              • Final dosage form manufacturing
              • Packaging
            • CRO
              • Drug Discovery
              • Preclinical studies
              • Early Phase I - IIa
              • Phase IIa - III
              • Phase IIIb - IV
              • Medical coding and writing
              • Monitoring
              • Clinical Data Management
              • Bio-statistics
              • Site management
              • Protocol development
          • Regulatory Information
        • By End User:
          • Healthcare Providers
          • Healthcare Payers
      • Canada
        • By Service Type:
          • Medical Device Outsourcing
          • Pharmaceutical Outsourcing
            • CMO
              • API Manufacturing
              • Final dosage form manufacturing
              • Packaging
            • CRO
              • Drug Discovery
              • Preclinical studies
              • Early Phase I - IIa
              • Phase IIa - III
              • Phase IIIb - IV
              • Medical coding and writing
              • Monitoring
              • Clinical Data Management
              • Bio-statistics
              • Site management
              • Protocol development
          • Regulatory Information
        • By End User:
          • Healthcare Providers
          • Healthcare Payers
    • Europe
      • UK
        • By Service Type:
          • Medical Device Outsourcing
          • Pharmaceutical Outsourcing
            • CMO
              • API Manufacturing
              • Final dosage form manufacturing
              • Packaging
            • CRO
              • Drug Discovery
              • Preclinical studies
              • Early Phase I - IIa
              • Phase IIa - III
              • Phase IIIb - IV
              • Medical coding and writing
              • Monitoring
              • Clinical Data Management
              • Bio-statistics
              • Site management
              • Protocol development
          • Regulatory Information
        • By End User:
          • Healthcare Providers
          • Healthcare Payers
      • Germany
        • By Service Type:
          • Medical Device Outsourcing
          • Pharmaceutical Outsourcing
            • CMO
              • API Manufacturing
              • Final dosage form manufacturing
              • Packaging
            • CRO
              • Drug Discovery
              • Preclinical studies
              • Early Phase I - IIa
              • Phase IIa - III
              • Phase IIIb - IV
              • Medical coding and writing
              • Monitoring
              • Clinical Data Management
              • Bio-statistics
              • Site management
              • Protocol development
          • Regulatory Information
        • By End User:
          • Healthcare Providers
          • Healthcare Payers
      • Italy
        • By Service Type:
          • Medical Device Outsourcing
          • Pharmaceutical Outsourcing
            • CMO
              • API Manufacturing
              • Final dosage form manufacturing
              • Packaging
            • CRO
              • Drug Discovery
              • Preclinical studies
              • Early Phase I - IIa
              • Phase IIa - III
              • Phase IIIb - IV
              • Medical coding and writing
              • Monitoring
              • Clinical Data Management
              • Bio-statistics
              • Site management
              • Protocol development
          • Regulatory Information
        • By End User:
          • Healthcare Providers
          • Healthcare Payers
      • France
        • By Service Type:
          • Medical Device Outsourcing
          • Pharmaceutical Outsourcing
            • CMO
              • API Manufacturing
              • Final dosage form manufacturing
              • Packaging
            • CRO
              • Drug Discovery
              • Preclinical studies
              • Early Phase I - IIa
              • Phase IIa - III
              • Phase IIIb - IV
              • Medical coding and writing
              • Monitoring
              • Clinical Data Management
              • Bio-statistics
              • Site management
              • Protocol development
          • Regulatory Information
        • By End User:
          • Healthcare Providers
          • Healthcare Payers
      • Russia
        • By Service Type:
          • Medical Device Outsourcing
          • Pharmaceutical Outsourcing
            • CMO
              • API Manufacturing
              • Final dosage form manufacturing
              • Packaging
            • CRO
              • Drug Discovery
              • Preclinical studies
              • Early Phase I - IIa
              • Phase IIa - III
              • Phase IIIb - IV
              • Medical coding and writing
              • Monitoring
              • Clinical Data Management
              • Bio-statistics
              • Site management
              • Protocol development
          • Regulatory Information
        • By End User:
          • Healthcare Providers
          • Healthcare Payers
      • Rest of Europe
        • By Service Type:
          • Medical Device Outsourcing
          • Pharmaceutical Outsourcing
            • CMO
              • API Manufacturing
              • Final dosage form manufacturing
              • Packaging
            • CRO
              • Drug Discovery
              • Preclinical studies
              • Early Phase I - IIa
              • Phase IIa - III
              • Phase IIIb - IV
              • Medical coding and writing
              • Monitoring
              • Clinical Data Management
              • Bio-statistics
              • Site management
              • Protocol development
          • Regulatory Information
        • By End User:
          • Healthcare Providers
          • Healthcare Payers
      • Asia-Pacific
        • China
          • By Service Type:
            • Medical Device Outsourcing
            • Pharmaceutical Outsourcing
              • CMO
                • API Manufacturing
                • Final dosage form manufacturing
                • Packaging
              • CRO
                • Drug Discovery
                • Preclinical studies
                • Early Phase I - IIa
                • Phase IIa - III
                • Phase IIIb - IV
                • Medical coding and writing
                • Monitoring
                • Clinical Data Management
                • Bio-statistics
                • Site management
                • Protocol development
            • Regulatory Information
          • By End User:
            • Healthcare Providers
            • Healthcare Payers
        • India
          • By Service Type:
            • Medical Device Outsourcing
            • Pharmaceutical Outsourcing
              • CMO
                • API Manufacturing
                • Final dosage form manufacturing
                • Packaging
              • CRO
                • Drug Discovery
                • Preclinical studies
                • Early Phase I - IIa
                • Phase IIa - III
                • Phase IIIb - IV
                • Medical coding and writing
                • Monitoring
                • Clinical Data Management
                • Bio-statistics
                • Site management
                • Protocol development
            • Regulatory Information
          • By End User:
            • Healthcare Providers
            • Healthcare Payers
        • Japan
          • By Service Type:
            • Medical Device Outsourcing
            • Pharmaceutical Outsourcing
              • CMO
                • API Manufacturing
                • Final dosage form manufacturing
                • Packaging
              • CRO
                • Drug Discovery
                • Preclinical studies
                • Early Phase I - IIa
                • Phase IIa - III
                • Phase IIIb - IV
                • Medical coding and writing
                • Monitoring
                • Clinical Data Management
                • Bio-statistics
                • Site management
                • Protocol development
            • Regulatory Information
          • By End User:
            • Healthcare Providers
            • Healthcare Payers
        • ASEAN
          • By Service Type:
            • Medical Device Outsourcing
            • Pharmaceutical Outsourcing
              • CMO
                • API Manufacturing
                • Final dosage form manufacturing
                • Packaging
              • CRO
                • Drug Discovery
                • Preclinical studies
                • Early Phase I - IIa
                • Phase IIa - III
                • Phase IIIb - IV
                • Medical coding and writing
                • Monitoring
                • Clinical Data Management
                • Bio-statistics
                • Site management
                • Protocol development
            • Regulatory Information
          • By End User:
            • Healthcare Providers
            • Healthcare Payers
        • Australia
          • By Service Type:
            • Medical Device Outsourcing
            • Pharmaceutical Outsourcing
              • CMO
                • API Manufacturing
                • Final dosage form manufacturing
                • Packaging
              • CRO
                • Drug Discovery
                • Preclinical studies
                • Early Phase I - IIa
                • Phase IIa - III
                • Phase IIIb - IV
                • Medical coding and writing
                • Monitoring
                • Clinical Data Management
                • Bio-statistics
                • Site management
                • Protocol development
            • Regulatory Information
          • By End User:
            • Healthcare Providers
            • Healthcare Payers
        • South Korea
          • By Service Type:
            • Medical Device Outsourcing
            • Pharmaceutical Outsourcing
              • CMO
                • API Manufacturing
                • Final dosage form manufacturing
                • Packaging
              • CRO
                • Drug Discovery
                • Preclinical studies
                • Early Phase I - IIa
                • Phase IIa - III
                • Phase IIIb - IV
                • Medical coding and writing
                • Monitoring
                • Clinical Data Management
                • Bio-statistics
                • Site management
                • Protocol development
            • Regulatory Information
          • By End User:
            • Healthcare Providers
            • Healthcare Payers
        • Rest of Asia Pacific
          • By Service Type:
            • Medical Device Outsourcing
            • Pharmaceutical Outsourcing
              • CMO
                • API Manufacturing
                • Final dosage form manufacturing
                • Packaging
              • CRO
                • Drug Discovery
                • Preclinical studies
                • Early Phase I - IIa
                • Phase IIa - III
                • Phase IIIb - IV
                • Medical coding and writing
                • Monitoring
                • Clinical Data Management
                • Bio-statistics
                • Site management
                • Protocol development
            • Regulatory Information
          • By End User:
            • Healthcare Providers
            • Healthcare Payers
    • Latin America
      • Brazil
        • By Service Type:
          • Medical Device Outsourcing
          • Pharmaceutical Outsourcing
            • CMO
              • API Manufacturing
              • Final dosage form manufacturing
              • Packaging
            • CRO
              • Drug Discovery
              • Preclinical studies
              • Early Phase I - IIa
              • Phase IIa - III
              • Phase IIIb - IV
              • Medical coding and writing
              • Monitoring
              • Clinical Data Management
              • Bio-statistics
              • Site management
              • Protocol development
          • Regulatory Information
        • By End User:
          • Healthcare Providers
          • Healthcare Payers
      • Mexico
        • By Service Type:
          • Medical Device Outsourcing
          • Pharmaceutical Outsourcing
            • CMO
              • API Manufacturing
              • Final dosage form manufacturing
              • Packaging
            • CRO
              • Drug Discovery
              • Preclinical studies
              • Early Phase I - IIa
              • Phase IIa - III
              • Phase IIIb - IV
              • Medical coding and writing
              • Monitoring
              • Clinical Data Management
              • Bio-statistics
              • Site management
              • Protocol development
          • Regulatory Information
        • By End User:
          • Healthcare Providers
          • Healthcare Payers
      • Rest of Latin America
        • By Service Type:
          • Medical Device Outsourcing
          • Pharmaceutical Outsourcing
            • CMO
              • API Manufacturing
              • Final dosage form manufacturing
              • Packaging
            • CRO
              • Drug Discovery
              • Preclinical studies
              • Early Phase I - IIa
              • Phase IIa - III
              • Phase IIIb - IV
              • Medical coding and writing
              • Monitoring
              • Clinical Data Management
              • Bio-statistics
              • Site management
              • Protocol development
          • Regulatory Information
        • By End User:
          • Healthcare Providers
          • Healthcare Payers
    • Middle East
      • GCC
        • By Service Type:
          • Medical Device Outsourcing
          • Pharmaceutical Outsourcing
            • CMO
              • API Manufacturing
              • Final dosage form manufacturing
              • Packaging
            • CRO
              • Drug Discovery
              • Preclinical studies
              • Early Phase I - IIa
              • Phase IIa - III
              • Phase IIIb - IV
              • Medical coding and writing
              • Monitoring
              • Clinical Data Management
              • Bio-statistics
              • Site management
              • Protocol development
          • Regulatory Information
        • By End User:
          • Healthcare Providers
          • Healthcare Payers
      • Israel
        • By Service Type:
          • Medical Device Outsourcing
          • Pharmaceutical Outsourcing
            • CMO
              • API Manufacturing
              • Final dosage form manufacturing
              • Packaging
            • CRO
              • Drug Discovery
              • Preclinical studies
              • Early Phase I - IIa
              • Phase IIa - III
              • Phase IIIb - IV
              • Medical coding and writing
              • Monitoring
              • Clinical Data Management
              • Bio-statistics
              • Site management
              • Protocol development
          • Regulatory Information
        • By End User:
          • Healthcare Providers
          • Healthcare Payers
    • Africa
      • North Africa
        • By Service Type:
          • Medical Device Outsourcing
          • Pharmaceutical Outsourcing
            • CMO
              • API Manufacturing
              • Final dosage form manufacturing
              • Packaging
            • CRO
              • Drug Discovery
              • Preclinical studies
              • Early Phase I - IIa
              • Phase IIa - III
              • Phase IIIb - IV
              • Medical coding and writing
              • Monitoring
              • Clinical Data Management
              • Bio-statistics
              • Site management
              • Protocol development
          • Regulatory Information
        • By End User:
          • Healthcare Providers
          • Healthcare Payers
      • Central Africa
        • By Service Type:
          • Medical Device Outsourcing
          • Pharmaceutical Outsourcing
            • CMO
              • API Manufacturing
              • Final dosage form manufacturing
              • Packaging
            • CRO
              • Drug Discovery
              • Preclinical studies
              • Early Phase I - IIa
              • Phase IIa - III
              • Phase IIIb - IV
              • Medical coding and writing
              • Monitoring
              • Clinical Data Management
              • Bio-statistics
              • Site management
              • Protocol development
          • Regulatory Information
        • By End User:
          • Healthcare Providers
          • Healthcare Payers
      • South Africa
        • By Service Type:
          • Medical Device Outsourcing
          • Pharmaceutical Outsourcing
            • CMO
              • API Manufacturing
              • Final dosage form manufacturing
              • Packaging
            • CRO
              • Drug Discovery
              • Preclinical studies
              • Early Phase I - IIa
              • Phase IIa - III
              • Phase IIIb - IV
              • Medical coding and writing
              • Monitoring
              • Clinical Data Management
              • Bio-statistics
              • Site management
              • Protocol development
          • Regulatory Information
        • By End User:
          • Healthcare Providers
          • Healthcare Payers
  • Company Profiles
    • Anthelio Healthcare Solutions*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
      • Future Plans
    • Accenture plc
    • Cognizant Technology Solutions
    • Catalent, Inc.
    • Covance, Inc.
    • Boehringer Ingelheim GmbH
    • Genpact Limited
    • Lonza Group
    • PAREXEL International Corporation
    • Quintiles Transnational Corporation

 

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet By Service
      • Market Snippet By End-User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
        • Supply Side Drivers
        • Demand Side Drivers
        • Economic Drivers
      • Restraints
      • Market Opportunities
      • Industry Trend
      • Merger and Acquisitions
    • Cost Tier Down Analysis
  4. Global Life Science BPO Market, By Service, 2014 - 2024 (USD Million)
    • Introduction
      • Market Share Analysis, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, 2014 - 2024
      • Segment Trends
    • Pharmaceutical Outsourcing
      • Introduction
      • Market Share Analysis, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, 2014 – 2024
      • Segment Trends
    • CMO
      •  Introduction
        • Market Share Analysis, 2015 and 2024 (%)
        • Y-O-Y Growth Analysis, 2014 - 2024
      • API Manufacturing
        • Introduction
        • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD  Million)
      • Dosage Form Manufacturing
        • Introduction
        • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD  Million)
      • Product Packaging
        • Introduction
        • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD  Million)
    • CRO
      •  Introduction
        • Market Share Analysis, 2015 and 2024 (%)
        • Y-O-Y Growth Analysis, 2014 - 2024
      • Drug Discovery
        • Introduction
        • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD  Million)
      • Preclinical Studies
        • Introduction
        • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD  Million)
      • Phase I Studies
        • Introduction
        • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD  Million)
      • Phase II Studies
        • Introduction
        • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD  Million)
      • Phase III and IV Studies
        • Introduction
        • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD  Million)
      • Medical Coding and Writing
        • Introduction
        • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD  Million)
      • Patient Monitoring
        • Introduction
        • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD  Million)
      • Clinical Data Management
        • Introduction
        • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD  Million)
      • Site Management
        • Introduction
        • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD  Million)
      •  Bio-Statistics
        • Introduction
        • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD  Million)
      • Protocol Development
        • Introduction
        • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD  Million)
    • Medical Device Outsourcing
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD  Million)
    • Regulatory Information
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD  Million)
  5. Global Life Science BPO Market, By End-User, 2014 - 2024 (USD Million)
    • Introduction
      • Market Share Analysis, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, 2014 - 2024
      • Segment Trends
    • Healthcare Providers
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD  Million)
    • Healthcare Payers
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2014 - 2024, (USD  Million)
  6. Global Life Science BPO Market, By Regions, 2014 - 2024 (USD Million)
    • Introduction
      • Market Share Analysis, By Region, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, For Regions, 2014 - 2024
    • North America
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • U.S.
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
        • Canada
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
    • Europe
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 – 2024
        • U.K.
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
        • Germany
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
        • Italy
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
        • France
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
        • Russia
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
        • Others
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
    • Asia Pacific
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • China
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
        • India
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
        • Japan
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
        • ASEAN
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
        • Australia
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
        • South Korea
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
        • Others
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
    • Latin America
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • Brazil
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
        • Mexico
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
        • Others
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
    • Africa
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • Northern Africa
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
        • Central Africa
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
        • South Africa
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
    • Middle East
      • Market Share Analysis, By Country, 2015 and 2024 (%)
      • Y-O-Y Growth Analysis, By Country, 2014 - 2024
        • GCC Countries
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
        • Israel
          • Country Trends
          • Market Size and Forecast, By Service, 2014 - 2024 (USD Million)
          • Market Size and Forecast, By End-User, 2014 - 2024 (USD Million)
  7. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
    • Company Profiles
      • Accenture plc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Anthelio Healthcare Solutions
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Boehringer Ingelheim GmbH
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Catalent, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Covance, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Genpact Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • ICON plc
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Infosys Limited
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • International Business Machines Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Lonza Group
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • PAREXEL International Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Quintiles Transnational Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
    • Analyst Views
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.